OxyContin

OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...

First out-licensing deal as Horizon tries to drive Duexis for pain

Horizon Pharma has exclusively licensed its pain product Duexis to German-headquartered Grunenthal for commercialisation in Latin America. "As this is our first out-license of Duexis outside the US,...

Horizon, Mallinckrodt to co-promote Duexis in US

Horizon Pharma and Mallinckrodt,the pharmaceuticals business of Covidien(COV), have signed a US co-promotion agreement for DUEXIS (ibuprofen and famotidine).

[Grunenthal] gets Latin American rights to [Horizon Pharma]'s {Duexis}

[Horizon Pharma Inc.] (drugs for pain and inflammatory conditions) has licensed pain management specialist [Grunenthal GMBH] exclusive rights to commercialize {Duexis} (famotidine/ibuprofen) in Latin...

[Horizon Pharma] grants [Mallinckrodt LLC] US co-promote rights to {Duexis}

[Horizon Pharma Inc.] (therapies for pain and inflammation) has granted [Covidien Ltd.]’s pharmaceutical subsidiary [Mallinckrodt LLC] US co-promotion rights to its {Duexis} (ibuprofen and famotidin...

[Horizon Pharma] grants [Mallincrodt LLC] US co-promote rights to {Duexis}

[Horizon Pharma Inc.] (therapies for pain and inflammation) has granted [Covidien Ltd.]’s pharmaceutical subsidiary [Mallinckrodt LLC] US co-promotion rights to its {Duexis} (ibuprofen and famotidin...

Grunenthal, Horizon sign commercialization contract for Duexis in Latin America

Horizon Pharma has signed a commercialization agreement with Grunenthal for Duexis in Latin America.

Grunenthal to commercialize Horizon Pharma's DUEXIS in Latin America

Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced tha...

Horizon's combo drug Duexis cuts ulcer risk in study

A study found that Horizon Pharma's arthritis drug Duexis, which combines famotidine and ibuprofen, reduces ulcer risk caused -More- 

A fixed-dose combination ibuprofen and famotidine (Duexis).

Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction.

We examined the prevalence of narcotic use before and after total knee arthroplasty (TKA) and its association with post-TKA pain relief and satisfaction. Data on 6364 primary, unilateral TKA patients...

Shared characteristics of suicides and other unnatural deaths following non-fatal self-harm? A multicentre study of risk factors.

BACKGROUND: Mortality, including suicide and accidents, is elevated in self-harm populations. Although risk factors for suicide following self-harm are often investigated, rarely have those for accide...

Transversus abdominis plane block for postoperative analgesia after cesarean delivery.

Objective: The transversus abdominis plane (TAP) block is the ultrasound-guided placement of a peripheral nerve block in the abdominal wall for pain control. Our objective was to compare postoperative...

Prevalence of psychoactive substances use in a Lithuanian women's prison revisited after 5 years.

Background: This paper re-examines the prevalence of psychoactive substances (tobacco, alcohol, narcotic drugs) use among inmates in a Lithuanian women's prison. The main goal of this study was to det...